Zoll Medical (ZOLL) +18.8% at the open, after reporting FQ4 EPS of $0.52, vs. $0.33 in the...

|About: Zoll Medical Corporation (ZOLL)|By:, SA News Editor

Zoll Medical (ZOLL) +18.8% at the open, after reporting FQ4 EPS of $0.52, vs. $0.33 in the year-ago period and better than analyst estimates of $0.49, and a 65% rise in profit on strong sales of its LifeVest device. The maker of defibrillators forecasts 2012 revenue will rise as much as 19% vs. analyst consensus of ~16%, and reports a $50M share buyback program.